Malaysia Pharmaceuticals and Healthcare Report Q3 2012Business Monitor International
July 10, 2012
111 Pages - SKU: BMI3957587
More Prescription Drugs reports by Business Monitor International
Sudan and South Sudan Pharmaceuticals and Healthcare Report Q3 2013 by Business Monitor International
BMI View: Sudan will remain one of the least attractive countries in the Middle East/Africa region due tolow pharmaceutical and healthcare expenditure. The government's low ...
Pakistan Pharmaceuticals and Healthcare Report Q3 2013 by Business Monitor International
BMI View: Increased longevity in developed markets translates into an increased demand for aged carehealthcare services and medicines. However, in emerging markets such as Pakistan, ...
Japan Pharmaceuticals and Healthcare Report Q3 2013 by Business Monitor International
BMI View: Japan remains the most attractive market in the Asia Pacific, due to the ageing and affluentpopulation and strong regulatory conditions. In particular, we ...
Croatia Pharmaceuticals and Healthcare Report Q3 2013 by Business Monitor InternationalSee all reports like this >>
Executive SummaryBMI View: Croatia's entrance into the EU will accelerate its economic liberalisation and the developmentof the country's private sector. It is also likely to ...
More Malaysia Prescription Drugs reports
Malaysia Pharmaceuticals and Healthcare Report Q2 2013 by Business Monitor International
BMI View: We have revised our pharmaceutical and healthcare market forecasts upwards for Malaysiathis quarter, because of continued signs of strong growth, and a clear ...
Malaysia Pharmaceuticals and Healthcare Report Q1 2013 by Business Monitor International
BMI View: Malaysia's healthcare sector is showing strong signs of growth, with increased internal andinvestment in pharmaceutical manufacturing facilities in a move to boost exports. ...
Malaysia Pharmaceuticals and Healthcare Report Q4 2012 by Business Monitor International
BMI View: Malaysia may have one of the region’s lowest per capita spend in terms of healthcare as apercentage of GDP – 4.3% in 2011 ...
Antibiotics Market in Malaysia to 2016 by Global Research & Data ServicesSee all reports like this >>
This market research report offers a perspective on the actual market situation, trends and future outlook for antibiotics in Malaysia. The study provides essential market ...
More Malaysia reports
D&B Country RiskLine Report: Malaysia by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
PCs - Malaysia - a snapshot (2010) by Mintel - Snapshots
PCs in Malaysia by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2010. This market covers desktop ...
Malaysia: Country Profile by MarketLine
INTRODUCTIONThis report provides a detailed analysis on Malaysia, providing an overview of its political, economic and business environment, represented both textually and in graph and ...
2007 Malaysia Industry & Market Outlook report by Barnes ReportsSee all reports like this >>
The 2007 Malaysia Industry & Market Outlook report is the leading annual publication that describes over 100 major industries in Malaysia and 500+ minor industries ...
We can help you find what you need. Call us or write us:
Need help in your search?
- Hospitals & Clinics
- Country Overviews
- Life Sciences
- Country Overviews
- Manufacturing, Packaging & Detailing
- Prescription Drugs
Prescription Drugs Reports